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Background
Vitiligo is an acquired, hypomelanotic skin disorder
characterized by circumscribed de-pigmented macules
resulting from the loss of functional melanocytes. Var-
ious factors which may be responsible for precipitating
this disorder in susceptible patients are oxidative stress,
auto-immunity and neurochemicals.
Materials and methods
The skin samples were obtained with the consent of
healthy individuals. Isolation of melanocytes was done
according to the standard method [1] and normal
human melanocytes (NHM) were grown in basal med-
ium supplemented with growth factors. Dose dependent
effect of different cytokines such as TNFa, IL6 and IL10
on NHM growth and proliferation was studied. MTT
assay, RNA isolation, cDNA synthesis and relative gene
expression studies were performed as described. This
study was approved by the Institutional Ethical Commit-
tee for Human Research (IECHR), The M. S. University
of Baroda, Vadodara, Gujarat, India.
Results
The pro-inflammatory cytokines (TNFa and IL6) induced
37% & 20% cell death respectively in NHM, on the other
hand the anti-inflammatory cytokine, IL10 did not affect
the growth of NHM (Fig.1). Our earlier studies have
shown high systemic mRNA and protein levels of TNFa
and TNFb in Gujarat vitiligo patients compared to controls
[2,3]. We have studied dose dependent effect of TNFa on
NHM, and found that TNFa induced cell death in a dose
dependent manner. Interestingly, higher concentrations of
TNFa induced up-regulation of its receptors TNFR1 &
TNFR2 along with significant increase in IL6 and ICA-
M1expression (Fig. 2). IL6 was also found to increase the
expression of ICAM1[4], which favors the attachment of
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Figure 1 Dose dependent effect of TNFa (A), IL6 (B) and IL10 (C) on normal human melanocyte growth and proliferation.
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T cells and melanocytes and thus making the latter more
susceptible for auto-immune destruction. We have also
found the synergistic effect of TNFa and IL6 in inducing
NHM apoptosis. In addition, TNFa and IL6 were found to
aggravate their effects under oxidative stress.
Conclusions
The present study reveals that TNFa significantly induces
IL6, ICAM1, TNFR1 and TNFR2 expression. In addition
IL6 also induces ICAM1 expression [4]. ICAM1 enhances
T-cell and melanocyte attachment, thus augmenting mela-
nocyte destruction by immune system. Under oxidative
stress, which mimics the microenvironment of vitiligo,
TNFA is found to enhance apoptosis of melanocytes
which would result in de-pigmentation of the skin. Thus,
our in vitro studies further strengthen the scientific evi-
dences linking oxidative stress and immune system to viti-
ligo pathogenesis giving credence to a convergent terminal
pathway of oxidative stress-autoimmunity mediated mela-
nocyte loss.
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Figure 2 TNFa induced expression of ICAM1, IL6, TNFR1 and TNFR2.
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